EPISODE · Apr 28, 2026 · 1 MIN
The New Frontier in Neurological Research: Are GLP-1s Changing the Game?
from TheBrief.Health · host TheBrief.Health
GLP-1 receptor agonists are emerging as potential Alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond amyloid-focused treatments despite mixed clinical trial results.
What this episode covers
GLP-1 receptor agonists are emerging as potential Alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond amyloid-focused treatments despite mixed clinical trial results.
NOW PLAYING
The New Frontier in Neurological Research: Are GLP-1s Changing the Game?
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m